A low systemic inflammatory response index is associated with improved survival in adenoid cystic carcinoma patients
Xuanqi Feng,Zhongyang Sun,Yang Huang,Yu Zhang,Yanru Chen,Bin Deng
DOI: https://doi.org/10.1016/j.joms.2024.03.022
IF: 1.9
2024-03-28
Journal of Oral and Maxillofacial Surgery
Abstract:Background Predicting the long-term survival in adenoid cystic carcinoma(ACC) patients remains is challenging. Inflammatory cell-based indices are emerging as prognostic indicators of oncology. Purpose This study aimed to determine the associations between the preoperative systemic inflammatory response index (SIRI) and, systemic immunoinflammatory index (SII), and the 10-year survival rates in patients with ACC of the head and neck (ACCHN). Study Design, Setting, Sample This retrospective cohort study comprised ACCHNN patients treated at the Chinese People's Liberation Army General Hospital between November 2003 and December 2020. Predictor Variable The inflammatory response, assessed using the SIRI and SII, was the predictor variable, The optimal cut-off values were based on the maximum Youden index values (sensitivity + specificity-1), The patients were divided into two-group each, based on the SIRI (low, ≤ 0.15) and (high, > 0.15), and SII (low, ≤ 562.8 and high, > 562.8) values. Outcome Variable Overall survival (OS), or the number of days, weeks, or months between treatment initiation and death (or last follow-up date), was the primary outcome variable. Covariates The covariates were classified as demographic (age, gender, body mass index), medical (hypertension, diabetes), inflammatory (neutrophils, lymphocytes, monocytes, platelets, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, neutrophil-lymphocyte ratio), and perioperative (tumor stage, lymph node metastasis, tumor size, treatment type). Analyses Descriptive, univariate, and multivariate Cox proportional risk regression analyses were performed to determine whether the SIRI and SII were independent prognostic factors for OS. Kaplan–Meier survival curves and log-rank tests were used to determine their associations with the OS. Results The study sample comprised 162 patients (mean age, 52 ± 14; males, 39.5%). The median follow-up time was 6.81 ± 0.23, and the 10-year OS rate was 7.68 ± 0.25. The low and high SIRI groups comprised 109 and 53 patients, while the low and high SII groups comprised 116 and 46 patients, respectively. SIRI was identified as a prognostic factor ( P < 0.01; hazard ratio, 2.45; 95% confidence interval, 1.35–4.45). Conclusion and Relevance The SIRI has the advantages of reproducibility, convenience, non-invasiveness, and affordability, making it a promising prognostic inflammatory index for patients with ACCHN.
dentistry, oral surgery & medicine